What Is NAD+ and Why Does It Matter?
Before we talk about NMN, we need to understand NAD+ (nicotinamide adenine dinucleotide).
The Basic Biology
NAD+ is a coenzyme found in every cell. It exists in two forms: NAD+ (oxidized, active) and NADH (reduced, inactive). NAD+ is essential for energy production, DNA repair, sirtuin activation, circadian rhythms, and immune function.
The NAD+ Decline Problem
Here’s the critical part: NAD+ levels decline with age. By age 50, NAD+ levels are roughly 50% of what they were at age 20. This decline accelerates further in your 60s and 70s. This matters because lower NAD+ is associated with reduced mitochondrial function, impaired DNA repair, reduced sirtuin activity, circadian rhythm disruption, and worse metabolic health.
How NMN Fits In
NMN is a direct precursor to NAD+. Your cells can convert NMN directly into NAD+ via a single enzymatic step (using the enzyme NMNAT). The pathway: NMN → NMNAT (enzyme) → NAD+. This directness is why researchers and supplement companies tout NMN as superior to other NAD+ precursors.
The Key Question: Does Raising NAD+ Actually Help Humans?
In mice, raising NAD+ has been associated with improvements in metabolic health, mitochondrial function, lifespan, cognitive function, and physical performance. But mice aren’t humans, and longevity interventions don’t always translate. So what does the human evidence actually show?
The 2024 Human Evidence: What We Actually Know
The most important recent data comes from 2024 meta-analyses and randomized controlled trials. The most compelling data comes from a 2024 trial in older adults (mean age ~70) where participants took either 250mg of NMN daily or placebo for 12 weeks.
Results:
- Walking speed improved: The NMN group showed a statistically significant improvement in walking speed compared to placebo. This is a validated predictor of longevity and health in older adults.
- Sleep quality improved: Participants reported better sleep quality and sleep efficiency.
- Blood NAD+ increased: NAD+ levels rose measurably in the NMN group.
- No serious side effects: No adverse events were reported.
This is the strongest human evidence we have for NMN. It shows functional improvement in older adults, not just biochemical changes on a lab test.
What We Don’t Know
Most human trials have been short (8-12 weeks). We don’t have robust long-term safety data beyond a year. Sample sizes in human trials have been relatively small. Most trials measure biomarkers (NAD+ levels) or acute measures (walking speed), not lifespan. There’s no head-to-head comparison in humans of NMN vs. other NAD+ precursors in large trials. We don’t know the optimal dose for long-term use or if benefits persist long-term.
Why David Sinclair Takes NMN (And What That Actually Means)
David Sinclair, the Harvard longevity researcher who studies NAD+ and sirtuins, is famous for taking NMN himself. He’s a world expert on NAD+ biology who has spent two decades researching this pathway. His lab has published groundbreaking work on sirtuins and NAD+. His personal use is an existence proof, not a clinical trial.
His lab’s work demonstrated that in mice, NMN supplementation led to improved age-associated metabolic decline, enhanced energy metabolism, increased physical activity levels, better insulin sensitivity, and improved eye function.
Sinclair reportedly takes 1 gram (1000 mg) of NMN daily, well above what the 2024 human trials used (250-500 mg).
NMN vs NR: Which NAD+ Precursor Is Actually Better?
Both NMN and NR (nicotinamide riboside) are NAD+ precursors. NMN is directly converted to NAD+ via NMNAT in a single enzymatic step. NR is converted via NRK1/NRK2 in the first step, then additional steps downstream.
The 2024 human trial data used NMN and showed functional improvements. The largest body of recent human clinical trials has focused on NMN rather than NR.
If you’re just starting with NAD+ precursors, I’d lean toward NMN because: More recent human clinical trials have used NMN, the biochemical pathway is more direct, the 2024 data on functional outcomes is compelling, and it’s currently more widely available and researched.
Optimal NMN Dosage: What the Research Supports
250 mg daily: Safe, well-tolerated, showed improvements in walking speed and sleep in older adults (65-75 years). This is the dose with the most recent functional outcome data.
500 mg daily: Some studies have used this dose; it remains within the safe range but hasn’t shown proportionally greater benefits in the human trials conducted to date.
1000 mg daily: This is what David Sinclair reportedly takes, but it exceeds what’s been tested in most human clinical trials. It’s likely safe, but the evidence for additional benefit over 250-500 mg in humans is not robust.
Practical Protocol Recommendations
Conservative approach (best for beginners): Start with 250 mg daily. Take it in the morning with food for optimal absorption. After 4-8 weeks, you can assess how you feel and consider increasing if desired.
Moderate approach: 500 mg daily, either in a single dose or split into 250 mg morning and 250 mg afternoon. This is still well within the safety margins.
Aggressive approach: 1000 mg daily, but understand you’re going beyond what’s been rigorously tested in human trials. It’s likely safe, but you’re extending beyond the clinical evidence base.
Bioavailability: Standard vs. Liposomal vs. Sublingual
Standard NMN Capsules and Powder: Standard oral NMN is the form used in virtually all human clinical trials. The absorption is efficient. Take it with food, particularly food with some fat, for optimal absorption.
Liposomal NMN: One small study found liposomal NMN increased blood NAD+ levels by approximately 84% after four weeks. However, the sample size was very small (5 participants per group). No published studies have directly compared liposomal NMN to standard NMN in large populations. Manufacturers claiming “3-5 times more bioavailable” lack robust independent validation.
Sublingual NMN: Research shows approximately 30% of a 125 mg sublingual dose gets absorbed under the tongue, with the remainder being swallowed. This isn’t a practical advantage. Standard oral NMN achieves complete absorption through the digestive system, which is already very efficient.
My Recommendation: Choose standard NMN capsules or powder from a reputable manufacturer. It’s the most evidence-backed, most affordable, and most practical option.
Who Should Consider NMN? And Who Shouldn’t
Ideal Candidates for NMN Supplementation
- Adults over 50: This is where the research is most robust.
- People with metabolic concerns: The meta-analysis found NMN showed some benefit for triglyceride reduction in people with overweight/obesity.
- Serious about longevity science: If you’re optimizing multiple dimensions of aging, NMN fits logically as part of the stack.
- People experiencing age-related functional decline: The walking speed and sleep improvements suggest NMN might help with common complaints of aging.
Who Might Want to Avoid NMN or Proceed Cautiously
- Young, healthy people under 30: You likely have sufficient NAD+ levels.
- People with active cancer: Sirtuins have complex roles in cancer biology. Consult an oncologist before supplementing.
- People on medications that interact with NAD+ metabolism: Your doctor should review any supplement.
- Pregnant or nursing women: There’s minimal safety data in this population.
- People with certain genetic conditions: If you have a known metabolic disorder, get clearance before starting.
NMN as Part of a Comprehensive Longevity Strategy
NMN is not a silver bullet. The 2024 meta-analysis showed it raises NAD+ but doesn’t dramatically transform body composition or glucose control on its own. It’s a foundational intervention that works best when combined with other evidence-based practices.
A real longevity protocol includes:
- Exercise: Resistance training and aerobic activity both upregulate NAD+ and sirtuin pathways naturally.
- Caloric restriction or time restriction: Intermittent fasting and fasting windows activate sirtuins.
- Sleep optimization: NAD+ and sirtuins regulate circadian rhythm.
- Adequate protein and micronutrients: No supplement compensates for poor nutrition.
- Stress management: Chronic stress impairs NAD+ metabolism and sirtuin function.
How to Choose a High-Quality NMN Supplement
Third-Party Testing and Certificates of Analysis
Any reputable NMN manufacturer should provide a Certificate of Analysis (COA) from an independent third-party lab. This COA should verify NMN purity (should be 95%+), absence of contaminants (heavy metals, microbial contamination, residual solvents), and confirmed potency.
If a manufacturer won’t provide this, walk away. It’s the clearest signal they’re not invested in quality.
Source and Manufacturing Standards
Look for manufacturers that manufacture in cGMP certified facilities, source NMN from established suppliers, are transparent about sourcing and manufacturing processes, and have been in the longevity supplement space for several years.
Price and Value
- Fair range for 250 mg capsules: $0.50-$1.00 per capsule
- Fair range for 500 mg capsules: $0.75-$1.50 per capsule
- If you’re paying much more: You’re likely paying for marketing rather than quality
- If you’re paying much less: Quality and purity are probably compromised
Red Flags to Avoid
- No Certificate of Analysis available
- Claims of “patented” or “proprietary” NMN (it’s a standard molecule)
- Exaggerated health claims not supported by research
- No clear information about where the NMN is sourced
- Price that seems unusually high or unusually low
- No contact information or customer support
- Reviews that seem fake or obviously paid
Safety Profile and Potential Side Effects
The safety data on NMN is reassuring. Across all the clinical trials, no serious adverse events have been reported. At doses ranging from 250 mg to 1000 mg daily, NMN has been well-tolerated in healthy adults and older adults.
Reported Side Effects (Rare)
- Nausea: Typically mild, usually resolves with consistent use or if taken with food
- Mild headache: Rare, possibly related to rapid NAD+ increases
- Sleep disruption if taken too late: NMN can increase energy; take in morning/afternoon, not evening
- GI sensitivity: Some people report mild stomach discomfort, usually temporary
Key Takeaways
- NMN is a direct precursor to NAD+, a critical coenzyme that declines with age.
- 2024 human trials show functional benefits: improved walking speed and sleep quality in older adults at 250 mg daily.
- Optimal dosage is likely 250-500 mg daily; higher doses lack equivalent human clinical support.
- Standard NMN capsules are most evidence-backed; liposomal and sublingual forms lack robust comparative data.
- NMN is most valuable for people over 50 with optimized lifestyle practices.
- Choose products with third-party Certificates of Analysis verifying purity and potency.
- NMN is safe with no serious adverse effects reported, though long-term human data beyond 12 weeks is limited.
- Expect benefits to emerge gradually—give it 8-12 weeks of consistent use before assessing effects.
Health Disclaimer
This article is for informational and educational purposes only and should not be construed as medical advice. NMN is a supplement, not a drug, and is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare provider before starting any new supplement regimen, particularly if you are pregnant, nursing, taking medications, or have a pre-existing medical condition. The information presented here is based on current peer-reviewed research available as of the publication date, but individual results may vary. Grey Area Labs and the author are not responsible for adverse effects or interactions that may occur from supplement use.
Additional Resources
- NAD+ and Longevity: Understanding the Science
- NAD+ Precursors Compared: NMN vs NR
- The Best Longevity Supplements: NAD+, NMN, and GlyNAC
- Sirtuins and Longevity: The Science of Cellular Guardians
- The Complete Guide to Longevity Science
- Top Longevity Supplements: What Works and Why
- Caloric Restriction and Longevity
Stay Updated on Longevity Science
Subscribe to Accelerated for weekly insights on longevity science and AI → https://ryanbethencourt.substack.com
Each week, I break down the latest research, interview leading researchers in longevity science, and explore how AI and DeSci are accelerating our understanding of aging. Whether you’re a beginner exploring longevity science or you’re deep in the biotech/investment space, you’ll find actionable insights and the latest data.
Thanks for reading. The data on longevity science keeps getting more compelling. NMN is one tool in an expanding toolkit for healthspan extension. Use it wisely, measure your results, and adjust based on your individual response.
—Ryan Bethencourt
Ryan Bethencourt is a biotech investor, longevity science strategist, and author focused on the intersection of DeSci, AI, and lifespan extension. He is the founder of Grey Area Labs and writes on longevity science and emerging biotechnology at ryanbethencourt.substack.com.